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1163-115 Traditional Risk Factors Are Associated With Regional 
Left Ventricular Dysfunction in Asymptomatic 
Individuals: The Multi-Ethnic Study of Atherosclerosis 
(MESA)
Boaz D. Rosen, Mohammed Saad, Steve Shea, Khurram Nasir, Thor Edvardsen, Michael 
Jerosch-Herold, Shenghan Lai, David A. Bluemke, Joao AC Lima, Johns Hopkins 
Hospital, Baltimore, MD
Background: Coronary artery disease (CAD) is the main cause of LV dysfunction in USA
and Europe. Hence, LV dysfunction may begin as a regional process that eventually
progresses to global dysfunction. We hypothesized that different risk factors for CAD
would be related to regional LV dysfunction in asymptomatic individuals.
Methods: MESA is a large multicenter study focused on subclinical cardiovascular dis-
ease among individuals aged 45-84 years. We evaluated global and regional LV function
by MRI tagging in 841 participants. Peak midwall systolic circumferential strain (Ecc) was
analyzed by Harmonic Phase Imaging (HARP). Ecc below the 5th percentile was used as
an index of regional dysfunction in three coronary territories: left anterior descending
(LAD), circumflex (LCX) and right (RCA). Logistic regression was used to study the rela-
tionship between Ecc and traditional risk factors.
Results: After adjustment for age and gender, significant associations were noted
between elevated diastolic blood pressure (DBP), and presence of abnormal Ecc. Odds
ratios of having abnormal Ecc in the presence of DBP>=90mmHg were 3.5-5.2 in each of
the coronary regions, (p<0.05). Percentage of individuals with abnormal Ecc in RCA
region was 4.1%, 5.9% and 26.7% in individuals with DBP<85, 85-89 and >=90 mmHg
(p<0.01). A similar pattern was seen in other coronary territories, and also in the pres-
ence of increased total and LDL cholesterol. Existence of more than one risk factor was
associated with a substantially higher proportion of participants with abnormal Ecc. In
individuals with DBP<85 mmHg and cholesterol <200 mg%, 4.3% of the individuals had
abnormal Ecc-RCA, in the presence of either increased cholesterol or DBP, correspond-
ing percentages were 3.9% and 7.8%, respectively. When both risk factors existed, the
percentage of individuals with abnormal Ecc increased to 24.4% (<0.01). Similar findings
were seen in the other regions. A similar pattern was noted when increased DBP and
other risk factors.
Conclusions: Classic risk factors, especially increased DBP are associated with regional
LV dysfunction in asymptomatic individuals. This association is stronger when more than
one risk factor is involved.
1163-116 Neurohormones but Not Adrenomedullin Correlate With 
Left Ventricular Structure in Patients With Heart Failure: 
Results From an EARTH Substudy
Jens P. Hellermann, Tatsuo Shimosawa, Frank Ruschitzka, Kurt Quitzau, Inder Anand, 
Thomas F. Luescher, University Hospital Zurich, Zurich, Switzerland
Background: Adrenomedullin (ADM), mainly produced in cardiovascular tissue in
response to shear stress and stretch, has been proposed as marker for left ventricular
(LV) dysfunction in patients with heart failure (HF). Yet, data on longitudinal changes in
ADM serum concentrations and their relation to changes in LV-volume and function in
patients with HF are scarce.
Methods: In 642 patients with moderate to severe HF, plasma levels of ADM, brain natri-
uretic peptide (BNP), atrial natriuretic peptide (ANP), and big endothelin (B-ET-1) at
baseline and after 6 months follow-up were measured. LV-enddiastolic volume index
(LVEDVI), ejection fraction (EF), LV-mass index and wall stress were assessed with MRI.
Spearman`s Rho correlations were performed to assess longitudinal changes in the rela-
tionship between ADM and LV-volume and function changes as well as clinical baseline
variables.
Results: There was no association between ADM and clinical variables like BMI, sex or
NYHA class at baseline. ADM was highly correlated with age (P = 0.0220), B-ET-1 (P <
0.0001) and BNP (P = 0.0006) levels at baseline and at follow-up. ANP and BNP were
significantly and positively correlated with changes in LVEDVI, LV-Mass Index and LV-
Wall Stress but not ADM. In patients treated with darusentan, an endothelinA antagonist
and an ACE inhibitor or ARB, a negative correlation between ADM and LV-Wall Stress
was observed (Rho = -0.1753, P = 0.0241) compared to patients without ACE inhibitor or
ARB (Rho = 0.1693, P = 0.5133). Conclusions: In this so far largest dataset of longitudi-
nal follow-up in patients with HF, ADM appears not to be correlated with clinical variables
except age nor LV-volume or function. Neurohormones BNP and ANP are best related to
changes in LV-volumes, but not LV function. ACE inhibitors and endothelin receptor
antagonist neutralized their effect on ADM serum concentration. Thus, ADM is not a use-
ful marker for monitoring HF.
1163-117 Prognostic Value of Development of Atrial Fibrillation in 
Outpatients With Heart Failure: Data From the Italian 
Network on Congestive Heart Failure (IN-CHF Registry)
Gianna Fabbri, Samuele Baldasseroni, Maurizio Marini, Francesca Coppi, Anna Gentile, 
Lucio Gonzini, Marco Gorini, Franco Ingrillì, Aldo P. Maggioni, The IN-CHF Investigators, 
ANMCO Research Center, Florence, Italy
BACKGROUND: Atrial fibrillation (AF) is the most frequent arrhythmia in patients (pts)
with heart failure (HF) and is related with an adverse prognosis. The development of AF
in HF may worsen clinical profile. However, it is not completely understood whether new
onset of AF is a more severe prognostic determinant than the presence of chronic AF. 
AIM: To examine whether HF pts with presence, or occurence of AF, have a poorer prog-
nosis, compared to pts with sinus rhythm.
METHODS: We studied 4710 HF outpts from the IN-CHF registry, followed for two years.
Pts were stratified in three groups: A) synus rhythm at baseline and at 1 year (3776 pts,
80.2%), B) synus rhythm at baseline and AF at 1 year (159 pts, 3.4%), C) AF at baseline
and at 1 year (775 pts,16.4%). Two year mortality and hospitalization rates were
assessed for all pts.
RESULTS: Table shows the characteristics of groups at entry.
Two years mortality (A=5.3%, B=17.8%, C=7.2%) and hospitalisation rates (A=32.1%,
B=61.0%, C=36.9%) were higher in B than in C and A, p<.0001. Adjusted analysis con-
firms that development of AF in pts with HF is independently related to an adverse out-
come both in terms of mortality (B group: HR 3.0, CI 95% 1.9-4.5; C group: HR 1.4, CI
95% 0.9 -1.9 vs A) and hospital admissions (B group: HR 3.0, CI 95% 2.1- 4.2; C group:
HR 1.1, CI 95% 0.9-1.3 vs A).
CONCLUSIONS: Pts with new onset AF have a markedly reduced survival compared
with those with chronic or without AF. These findings suggest that AF is associated with a
worse outcome early after its development.
1163-118 Alcohol Consumption and Cardiac Structure and 
Function in American Indians: The Strong Heart Study
Marcello Chinali, Giovanni de Simone, Thomas K. Welty, Elisa T. Lee, Lyle G. Best, 
Barbara V. Howard, Richard B. Devereux, Weill Medical College of Cornell University, 
New York, NY
Background. Chronic alcohol intake has been considered as a possible cause of cardi-
omyopathy. However, it has been recently reported that alcohol consumption is not asso-
ciated with increased risk for congestive heart failure, even among heavy drinkers. This
study was designed to assess the relation between alcohol intake and preclinical cardiac
abnormalities in the population of the Strong Heart Study.
Methods. We studied 3,310 middle-aged to elderly participants of the study (age 59.6 ±
7.8 years, 63.8% women, 54.5% obese, 45.6% hypertensive, 47.5% diabetics), without
prevalent cardiovascular disease. Participants were divided into groups according to the
amount of self-reported alcohol intake. Quantities of alcoholic beverages were converted
to number of drinks (1 drink = 12oz of beer, 4 oz of wine or 1 shot of hard liquor). All par-
ticipants underwent clinical, laboratory and echocardiographic examination.
Results.Participants were divided in 1,147 never drinkers (N), 1,387 former drinkers (FD;
defined as no alcohol for at least 12 months), and 776 drinkers (404 were light drinkers
(LD)>4 drinks/week, 220 were moderate drinkers (MD) 4 to 12 drinks/week, and 157
were heavy drinkers (HD)>12 drinks/week). Drinking was more frequently associated
with male gender, younger age, and higher diastolic blood pressure (p for trend all
<0.01). Similar prevalence of diabetes, hypertension and obesity was found in all five
groups (for all p=ns). All three drinking groups showed higher values of left ventricular
diameter, cardiac output and aortic root diameter as compared with both the never and
the former drinkers (all p<0.05). After controlling for clinical covariates there was no sig-
nificant difference in left ventricular structure among the five groups. However, HD was
still associated with increased aortic root diameter and higher cardiac output compared
to both never and former drinkers (p for both <0.01).
Conclusion. In a middle-aged to elderly population of American Indians, mild to moder-
ate alcohol consumption is not associated with preclinical cardiac abnormalities. How-
ever, heavy drinking is independently associated with increased aortic root diameter and
increased cardiac output.
1163-119 Changes of Inflammatory Cytokines and Uric Acid in 
Patients With Severe Chronic Heart Failure: A 
COPERNICUS Substudy
Stefan D. Anker, Aidan P. Bolger, Andrew JS Coats, Hugo A. Katus, Michael B. Fowler, 
Milton Packer, for the COPERNICUS Study Group, NHLI, London, United Kingdom, 
Applied Cachexia Research, Berlin, Germany
It is not known, whether changes in inflammatory cytokines and serum uric acid (UA)
relate to prognosisin in patients chronic heart failure (CHF), and whether the prognostic
benefits of carvedilol are related to such changes.
Methods: In 204 randomly selected patients (age 62±1y, LVEF: all <25%, BMI 26.6±0.3
kg/m2, female: 22%) participating in the Eurpean arm of the COPERNICUS study, we
evaluated plasma levels of tumor necrosis factor alpha (TNF), soluble TNF receptor-1
(sTNFR1), interleukin (IL-6), IL-1 receptor antagonist (IL-1RA) and serum UA at baseline
(BL) and after 115±6 days follow-up (FU, n=185).
Results: Mean levels of cytokines and UA are shown in the table. At BL, UA correlated
with sTNFR1 (r=0.29, p<0.0001, n=203) and IL-6 (r=0.26, p=0.001, n=154). During FU,
29 deaths were observed in this cohort (12-month mortality 15.4%). Adjusting for age,
gender, BMI and treatment, UA (p<0.03), but none of the cytokines predicted prognosis.
Considering changes of parameters vs subsequent survival, only increases in IL-1RA
(p<0.04) and UA (p<0.03) independently related to poor prognosis. An increase of UA by
1 mg/dL (i.e. 60 µmol/L) related to 39% higher mortality (95%CI 4-87%).
Conclusion: The beneficial effects of carvedilol in CHF are not dependent on plasma
A B C p
Age (mean±SD), yrs 62±12 67±9 67±10 <.0001
NYHA III-IV, % 22 33 33 <.0001
Ischemic etiology, % 42 38 21 <.0001
Ejection fraction >40%, % 24 27 33 0.0005
Anemia (Hb <12mg/dL), % 12 20 12 0.05
Creatinine >2.5 mg/dL, % 2 5 1 0.02
Beta-blockers yes, % 23 14 15 <.0001
ACE-inhibitors yes, % 84 75 80 0.0002
Amiodarone yes, % 20 30 16 <.0001
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levels of inflammatory cytokines or serum uric acid or their changes. Serum uric acid and
its changes independently predict poor prognosis in CHF, more acurately than do plasma
cytokines.
1163-120 Complement Activation in Patients With Congestive 
Heart Failure
Suhua Wu, Hong Ma, Yugang Dong, Jiangui He, Huiying Ye, Yujun Zhong, First Affiliated 
Hospital, Sun Yet-Sen University, Guangzhou, People's Republic of China
Background Increasing evidence suggests that complement may play a role in the
pathogenesis of myocardial damage secondary to ischemia and reperfusion, but the role
of complement in congestive heart failure is at present unclear. Objectives To determine
whether the complement system is activated and its relationship to clinical outcomes in
patients with congestive heart failure (CHF). Methods The plasma levels of products of
complement activation C4d (classic pathway), Bb (alternative pathway), 3bc (final com-
mon pathway) and C5b-9 (terminal complement complex) were measured by enzyme-
linked immunosorbent assay(ELISA) method in forty-four patients with CHF and sixteen
normal age and sex matched volunteers. The left ventricular ejection fractions of all
patients were measured by electron beam computed tomography (EBCT). Forty-one
patients with CHF were followed up for 13±3 months to determine the combined clinical
outcomes (hospitalization with worsening heart failure or death). Results Our major find-
ing were (1) The plasma levels of C4d, Bb, C3bc and C5b-9 in patients with CHF were
significantly higher than those in normal volunteers. (2) Significantly more of the patients
with highest levels of C5b-9 ( highest 50th percentile ) had worse left ventricular function
and adverse clinical outcomes compared with the patients with lowest levels of C5b-9 (
lowest 50th percentile). Conclusions We have observed an activation of complement
system and an association between high levels of C5b-9 and adverse clinical events in
patients with CHF. Our findings suggested that complement might be added to the list of
possible therapeutic targets.
1163-121 Prognostic Role of Neutrophil and Lymphocyte Counts 
in Heart Failure: Results From Val-HeFT
Inder S. Anand, Joseph Yen, Viorel G. Florea, Allen Hester, Robert Glazer, Roberto 
Latini, Aldo Maggioni, Jay N. Cohn, Veterans Affairs Medical Center and University of 
Minnesota, Minneapolis, MN
Background. Lymphocyte and neutrophil counts predict cardiovascular events in patients
with coronary artery disease. Their role in heart failure (HF), however, is not known. We
evaluated the prognostic value of baseline (BL) neutrophil and lymphocyte counts on
mortality and first morbid event (M&M;) in the Valsartan Heart Failure Trial (Val-HeFT).
Methods and Results. Blood counts were measured at BL and during follow-up. Cox pro-
portional hazards analysis was made for all cause mortality and M&M; with BL neutrophil
and lymphocyte counts, classified by median and quartile (Q) groupings and used as
independent variables in separate analyses. Patients with high BL neutrophil counts and
low BL lymphocyte counts had more advanced HF. Both neutrophil and lymphocyte
counts were significant multivariate predictors of mortality and M&M; when analyzed as
continuous, dichotomized or Q variables. Whereas, higher neutrophil count was associ-
ated with greater mortality and M&M;, higher BL lymphocyte count was associated with a
lower mortality and M&M;. Relative risk (RR) for neutrophils was 1.315 (95% CI 1.172 –
1.458; p=0.00016) and for lymphocytes 0.789 (95% CI 0.644 – 0.934, p=0.00131). Com-
parison of RRs and 95 % CIs with other dichotomized (> vs < median) multivariate pre-
dictors of mortality in descending order of p-value is shown in Table.
Conclusions: High BL neutrophil and low BL lymphocyte counts are important predictors
of outcomes in HF, suggesting a possible role of inflammation in the progression of HF.
1163-122 Does Wider QRS Reflect Heart Failure Severity?
Teresa De Marco, Michael B. Higginbotham, Leslie A. Saxon, Sudha Balasubramanian, 
Patrick Yong, Elyse Foster, University of California San Francisco, San Francisco, CA, 
Guidant Corporation, St. Paul, MN
Background: A wide QRS is used as a surrogate measure of ventricular dysynchrony for
selecting cardiac resynchronization therapy candidates. It is not clear if prolonged QRS
correlates with other baseline measures such as left ventricular structure, systolic func-
tion, exercise tolerance, and heart failure symptoms.
Methods: Patients participating in the VENTAK® CHF/CONTAK® CD Biventricular Pac-
ing Study were included in this retrospective analysis. Correlation of baseline QRS was
calculated for each of the following baseline parameters: left ventricular ejection fraction
(LVEF), LV internal dimension, systole (LVIDs), peak oxygen consumption (peak VO2),
six-minute walk distance (6MWD), quality of life (QOL; Minnesota living with heart failure
questionnaire) and NYHA class.
Results: At implant the study population consisted of 83% males, mean age 66 ± 10
years, NYHA II (33%), III (58%), IV (9%), mean LVEF 21±7%, mean QRS width 158 ± 28
ms. Baseline QRS significantly correlated with baseline LVEF, LVIDs, peak VO2, 6MWD
but not with QOL and NYHA Class.
Conclusions: Widening of the QRS is significantly associated with measures of heart
failure severity including greater LV dimension, lower LVEF and reduced exercise toler-
ance but does not correlate with measures of symptomatic status. If these findings can
be confirmed, then the degree of QRS prolongation in heart failure patients may serve as
an inexpensive and reliable surrogate indicator of these measures of heart failure sever-
ity.
1163-123 Relationship Between Plasma C-Reactive Protein 
Concentration on Admission and Long-Term Outcome 
in Unselected Hospitalized Heart Failure Patients
Colin Berry, Karen Hogg, Karen Stevenson, John Norrie, John J. McMurray, University of 
Glasgow, Glasgow, United Kingdom
Background: Although systemic inflammation is recognised in heart failure (HF) its impor-
tance in relation to outcome is uncertain. Plasma c-reactive protein (pCRP) concentration
is typically elevated in inflammatory conditions and is recognised as a marker of systemic
inflammation.
Methods: We studied all index emergency admissions with HF to one University hospital
(which provides exclusive acute medical care to the local urban district) during the year
2000. Echocardiography was undertaken by a single operator. Reduced LVSF was
defined as an ejection fraction of <40%. Hematological and biochemical data (from the
initial blood samples taken on the day of admission) were obtained from hospital elec-
tronic records. Information on death was obtained from the national record linkage data-
base for all patients.
Results: 528 consecutive first admissions with HF were identified. The median follow-up
was 693 days (range 1 - 978 days). Median (interquartile range) pCRP concentration was
16 (5, 183) mg/L, and 65% of patients had an elevated (> 10 mg/L) pCRP concentration.
45% and 35% of patients had a pCRP concentration greater than 20 and 30 mg/L,
respectively. Univariate predictors of an elevated pCRP concentration included hemoglo-
bin, hematocrit, white cell count (WCC), platelet count, serum creatinine concentration
and plasma fibrinogen, sodium and albumin concentrations. On multivariate analysis,
predictors (odds ratio, 95% CI) of pCRP concentration included WCC (1.9 [1.4, 2.9]),
fibrinogen count (1.9 [1.3, 2.6]), and albumin (0.7 [0.5, 0.9]). pCRP concentration was an
independent predictor of in-hospital survival (Cox proportional hazard ratio (HR) 0.2 per
SD (61 mg/L); 95% CI 0.1,0.6, P=0.001), and long-term mortality (CRP per SD, HR 1.4;
95% CI 1.2 -1.7; P <0.001 ).
Conclusion: Systemic inflammation, indicated by an elevated pCRP concentration, is
very common in hospitalized HF patients, and predicts long-term adverse outcome. That
CRP is an independent predictor of mortality suggests that this protein may have harmful
effects.
1163-124 Improvement in Autonomic Dysfunction Manifested by 
Altered Heart Rate Variability, T-Wave-Alternans and 
Norepinephrine by Long-Term Exercise in Chronic Heart 
Failure
Robert M. Nechwatal, Michael Horn, Uwe Scharf, Bettina Mochalski, Ulrike 
Lachenmeyer, Christiaan Barnard Klinik, Dahlen, Germany
Background: In recent years exercise training has become an established therapy for
patients with stable chronic heart failure. However there is a paucity of data on the effects
of long term training on autonomic dysfunction. Methods: 100 patients with DCM and
CHD were randomized to an exercise (n=50, mean age:49,9+-9,3,mean ejection fraction
(EF) 33,3+-5,7%)or to a control group (n=50, mean age:54,7+-11,3,EF: 32,4+-
5,3%).Patients underwent six 20 minute supervised training sessions per week at a VO2
of 60% VO2peak. Before and after the six month study period exercise testing with respi-
ratory gas exchange, heart rate variability in the time domain on holter monitoring, nore-
pinephrine plasma values and T-wave alternans testing were performed. Results:See
Table.VO2AT: oxygen uptake at the anaerobic threshold. *: p<0,05 **: p<0,01 vs pre-
training.id: indeterminate. 10 patients in the exercise group and 2 in the control group did
not complete the protocol: one of each group died unassociated with exercise, one of
Table (for changes over time between drugs: all p>0.2)
Time point TNF sTNFR1 IL-6 IL1-RA Uric Acid
(pg/mL) (pg/mL) (pg/mL) (pg/mL) (mg/dL)
Carvedilol-BL 2.20±0.14 1575±79 3.25±0.30 400±25 7.26±0.24
Carvedilol-FU 2.13±0.22 1615±72 3.53±0.32 406±27 7.47±0.23
Placebo-BL 1.92±0.11 1589±59 3.26±0.25 410±39 7.24±0.23
Placebo-FU 1.96±0.26 1621±80 3.84±0.32 409±30 7.11±0.25
Variable BNP NYHA, III 
and IV
LVIDD/
BSA
Uric 
Acid
Neutrop
hils
Plasma 
Renin 
Activity
Beta 
Blocke
r Use
Lympho
cytes
Norepin
ephrine
Age, 
>65 yrs
Ischem
ic 
etiolog
y
Creatini
ne
Relative 
Risk
1.906 1.398 1.354 1.357 1.315 1.324 0.754 0.789 1.272 1.260 1.208 1.206
95% CI 1.748, 
2.065
1.257, 
1.539
1.211, 
1.497
1.206, 
1.508
1.172, 
1.458
1.177, 
1.471
0.597, 
0.910
0.644, 
0.934
1.125, 
1.419
1.113, 
1.407
1.059, 
1.357
1.053, 
1.358
p-Value <0.00001 <0.00001 0.00003 0.00007 0.00016 0.00018 0.0004 0.00131 0.00132 0.00216 0.0123 0.01701
Variable
 N  Correlation  P-value
LVEF at Baseline
 500  -0.17  <0.01
LVIDs at Baseline
 420  0.27  <0.01
Peak VO2 at Baseline
 382  -0.11  0.03
6 MWD at Baseline
 438  -0.12  0.02
QOL at Baseline
 457  0.03  0.59
NYHA at Baseline
 465  0.08  0.10
